Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Which rewards card is better for travel? Explore options to maximize your travel benefits and choose the right card for you.
22,786 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
A surge in Redwire shares mirrors a broader buzz around space stocks. Learn what’s driving the rally, what it means f...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
For the 16th straight week, home listing prices fall across many markets as higher borrowing costs and rising invento...
ICP bucked a broad market downturn, edging higher while Bitcoin and Ethereum slumped. On-chain metrics and ecosystem ...
When a stock plunges, it’s easy to blame the hype. This week, planet labs stock plummeting has investors weighing ear...
AI stocks have dazzled markets, but Bill Ackman warns that hype can outrun fundamentals. This guide breaks down the r...
Workday introduces AI-driven updates to its Adaptive Planning platform to curb spreadsheet chaos in FP&A. The move ta...
Investors are weighing DISV and ISVL for international small-cap value exposure, focusing on whether their dividend s...
Cathie Wood and Ark Invest pulled cash from several holdings in a single session, sparking questions about risk, liqu...
Confused by Rocket Lab's stock moves? This guide explains the core forces behind RKLB, how the business is evolving, ...